TSX-011
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TSX-011, covering 2019-05-16 to 2019-05-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males [Phase 1, Phase 2]